Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMT... (catastrophic impact on our troops. ...)

HOME >> BIOLOGY >> TECHNOLOGY

Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program

Date:12/14/2007

catastrophic impact on our troops.

The program embodies the principles in the recently signed Homeland

Security Presidential Directive-18, which directs Federal agencies to

undertake efforts to combat biological threats for which we do not

currently have countermeasures. Funding of the program at the requested

level for FY 2008 is required to maintain execution of the FY 2006 and

FY 2007 innovations and to address capability gaps. A reduction of $100

million would continue to underfund this effort and dramatically reduce

the potential to develop and deliver products for transition to advanced

development by the end of FY 2010."

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and hepatitis C virus (HCV) infection. The company is pursuing three separate clinical programs in cancer and HCV infection with its lead product candidates bavituximab and Cotara(R). Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (http://www.avidbio.com), which provides development and bio-manufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at http://www.peregrineinc.com.

Safe Harbor Statement: Statements in this press release which are not purely historical, including statements regarding Peregrine Pharmaceuticals' intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements involve risks and uncertainties including, but not limited to, the ris
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related biology technology :

1. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
2. ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information
3. CHS Receives Prestigious Honor from Department of Defense
4. GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
5. Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development
6. Implicit Awarded US $16.3 Million U.S. Government Contract to Develop Immunomodulatory Drug for Biodefense Threats
7. ICx Awarded Department of Defense Contract for AirSentinel Monitors
8. Taming the anthrax threat
9. Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health
10. Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health
11. Taming the anthrax threat

Post Your Comments:

(Date:5/12/2008)...e Webcast -, MONTVALE, N.J., May 12 /PRNewswire-F...YI ) announced today that Noah Berkowitz, M.D., Ph...sta will present at the upcoming Rodman,& Renshaw ... May 19, 2008,at 12:10 p.m. CEST (6:10 a.m. EDT). ... Le Meridien Beach Plaza Hotel in Monte Carlo., D...

(Date:5/12/2008)...nformed Medical Communications,(IMC), a leading pr...pharmaceutical industry, today announced the appoi...eting. In this role, Stoogenke will,develop and im...logue and,IMC with the objective to maintain and g...Logo: http://www.newscom.com/cgi-bin/prnh/2008051...

(Date:5/12/2008)... the community and its biotech ...swire-FirstCall/ -- Eli Lilly and Company,(NYSE: ...e of its $1 billion,effort to further strengthen t...t capabilities., At a ceremony at its Indianapoli...ation by Indianapolis Mayor Gregory Ballard, dedic...

(Date:5/12/2008)...-FirstCall/ -- Nektar,Therapeutics (Nasdaq: NKTR ...n technology is used in the novel therapeutic, Hem...is-stimulating agent that is under,development by ...and,Affymax. Data were presented for Hematide(TM) ...Sweden, which showed that Hematide(TM) administere...

Breaking Biology Technology:Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference 2 Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference 3 Informed Medical Communications Hires New Vice President of Marketing 2 Lilly Completes Final Phase of Its Indianapolis Biotechnology Complex 2 Lilly Completes Final Phase of Its Indianapolis Biotechnology Complex 3 Nektar's PEGylation Technology Enables Peptide Mimetic, Highlighted by Data Presented at 45th ERA-EDTA Congress 2 Nektar's PEGylation Technology Enables Peptide Mimetic, Highlighted by Data Presented at 45th ERA-EDTA Congress 3

[0] Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference [0] Informed Medical Communications Hires New Vice President of Marketing [1] Lilly Completes Final Phase of Its Indianapolis Biotechnology Complex [0] Nektar's PEGylation Technology Enables Peptide Mimetic, Highlighted by Data Presented at 45th ERA-EDTA Congress

...iana Davis, Aiguo Zhang, Jim Torrence, and Emily D...el Drive, Hercules, CA 94547 USA , , ...assays are bead-based quantitative multiplex immun... in these assays are quantitated using a , ...ysis is performed to derive , an equation...

...hloe Etienne, Allan Gandy, Diana Davis, and Aiguo ...obel Drive, Hercules, CA 94547 USA , , ...pension array system is an integrated system consi...kits. The system employs bead-based Luminex , ...0 targets in a single microplate , well. ...

...ian Gao, Kris Simonyi, and Claudia Suen, Bio-Rad L...ules, CA 94547 USA , , Introduc...l technique for detecting phosphorylated , ...ssue sample lysates. In , recent years, n...re approach , have become available for d...

..., AquaPure RNA Isolation Kit , ...ple and RNA expression levels , , ...ndling , Samples may be fresh or frozen... quickly as possible; store at 18C for not more t... at -70 to -80C. , Cell Lysis , ...

Other Biology Technology:Selection of Standards for Bio-Plex Cytokine Assays, Rev A 2 Selection of Standards for Bio-Plex Cytokine Assays, Rev A 3 Selection of Standards for Bio-Plex Cytokine Assays, Rev A 4 Selection of Standards for Bio-Plex Cytokine Assays, Rev A 5 Selection of Standards for Bio-Plex Cytokine Assays, Rev A 6 Selection of Standards for Bio-Plex Cytokine Assays, Rev A 7 Selection of Standards for Bio-Plex Cytokine Assays, Rev A 8 Correlation of Bio-Plex Suspension Array Reader Validation With Multiplex Cytokine Assay Performance, Rev A 2 Correlation of Bio-Plex Suspension Array Reader Validation With Multiplex Cytokine Assay Performance, Rev A 3 Correlation of Bio-Plex Suspension Array Reader Validation With Multiplex Cytokine Assay Performance, Rev A 4 Correlation of Bio-Plex Suspension Array Reader Validation With Multiplex Cytokine Assay Performance, Rev A 5 Detection of Phosphorylated and Total ERK and p38 MAPK by Bio-Plex Assay, ELISA, and Western Blotting, Rev A 2 Detection of Phosphorylated and Total ERK and p38 MAPK by Bio-Plex Assay, ELISA, and Western Blotting, Rev A 3 Detection of Phosphorylated and Total ERK and p38 MAPK by Bio-Plex Assay, ELISA, and Western Blotting, Rev A 4 Detection of Phosphorylated and Total ERK and p38 MAPK by Bio-Plex Assay, ELISA, and Western Blotting, Rev A 5 Total RNA Isolation: 100 l Viral Sample From Cultured-Cell Supernatant Containing Virus 2

Selection of Standards for Bio-Plex Cytokine Assays, Rev A Correlation of Bio-Plex Suspension Array Reader Validation With Multiplex Cytokine Assay Performance, Rev A Detection of Phosphorylated and Total ERK and p38 MAPK by Bio-Plex Assay, ELISA, and Western Blotting, Rev A Total RNA Isolation: 100 l Viral Sample From Cultured-Cell Supernatant Containing Virus

(Date:5/12/2008)..., 2008 There exists much ethical controversy brou...the relationship to religion. In a new essay in Th... takes an approach to medical ethics that draws up...w how acting to change the world is indicative of ...r how the natural world functions and why humans b...

(Date:5/12/2008)...evGenUK) is being launched at the John Innes Centr...ants grow. , This knowledge can be used to impr...ions or to grow more sustainably with reduced nitr...million from the Biotechnology and Biological Scie...on the JICs expertise in TILLING, a technique to d...

(Date:5/12/2008)...on years of evolution has taken two unlikely dista...rent physical paths from a common ancestor. But Un...tor protein, myosin 2, remains structurally identi...s that the tiny motor protein is much more importa...even hold a key to understanding potentially fatal...

(Date:5/12/2008)...ay released a 20-year study showing that environme...ve effect on reducing overall contaminant levels i...points to continuing concerns with elevated levels...an and industrial areas of the coasts. , Its... and industrial chemicals, such as PCBs, show sign...

Breaking Biology News(10 mins):Religion and the narrative of biological science 2 Ancient protein offers clues to killer condition 2 NOAA reports coastal waters show decline in contaminants 2 NOAA reports coastal waters show decline in contaminants 3 DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 1 DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 2 DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 3 DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 4 DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 5 DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 6 DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 7 DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 8 DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 9 DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 10 DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 11 DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 12 DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 13 DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 14 DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 15 DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 16 DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 17 DuPont Reports First Quarter Earnings Growth of Over 20 Percent 4753 18 Survey 3A Employers Have High Confidence They Can Control Health Care Costs With Proper Tools 17389 1 Survey 3A Employers Have High Confidence They Can Control Health Care Costs With Proper Tools 17389 2 Survey 3A Employers Have High Confidence They Can Control Health Care Costs With Proper Tools 17389 3 JIC Invests in Three New Alternative Energy Projects 4751 1 JIC Invests in Three New Alternative Energy Projects 4751 2 JIC Invests in Three New Alternative Energy Projects 4751 3 JIC Invests in Three New Alternative Energy Projects 4751 4 JIC Invests in Three New Alternative Energy Projects 4751 5 Fufeng Announces 2007 Annual Results 4750 1 Fufeng Announces 2007 Annual Results 4750 2 Fufeng Announces 2007 Annual Results 4750 3

[0] Religion and the narrative of biological science [0] RevGenUK, a 'single-stop' shop for use in functional genomics [0] Ancient protein offers clues to killer condition [0] NOAA reports coastal waters show decline in contaminants

...ed Hitchcock,s "The Birds" made many of us uneasy ...blic health officials around the world are beginni...birds, especially in Alaska, following recent outb...st week, in Siberia. , Alaska is at the intersecti...ratory birds and scientists say that could provide...

... University will lead an interdisciplinary team of...elp improve one of the most important food crops i...oundation selected the BioCassava Plus project as ...lenges in Global Health" program grants. Created t... is to fund innovative solutions to global health ...

...e studies of captive breeding strategies conducted...d sometimes troublesome breeding programs that pre...ions of endangered species. , Worldwide, zoos spen...animals thousands of miles in order to breed them ...have questioned the need for such programs, which ...

... have discovered that a group of important immune ...atic British superspy James Bond: the cells receiv...st potent attacks on enemies. , This licensing pro...cells will erroneously direct their firepower at t... Washington University School of Medicine in St. L...

Other Biology News:On a wing and a prayer - Alaska researchers seek clues to bird flu 2 On a wing and a prayer - Alaska researchers seek clues to bird flu 3 Research team receives $7.5 million to study cassava 2 Costly breeding programs for endangered species pay off 2 Costly breeding programs for endangered species pay off 3 'License to kill' enables powerful immune attack cells in mice 2 'License to kill' enables powerful immune attack cells in mice 3

On a wing and a prayer - Alaska researchers seek clues to bird flu Research team receives $7.5 million to study cassava Costly breeding programs for endangered species pay off 'License to kill' enables powerful immune attack cells in mice

Tracker Datamatrix RS-1* reads 96 2D Bar-coded tubes within 20 seconds.

Kit containing positive control DNA all parts of the HIV-1 genome, HIV-1 negative control DNA, Primers SK38, SK39, SK19

Request Info

Human TIMP-1 ELISpot Development Kit from R&D Systems

Biology Products:

Tracker Datamatrix RS-1* from Micronic BV GeneAmplimer HIV-1 Control Reagents from Applied Biosystems pPDM-1 Cloning Plasmid from EPICENTRE Biotechnologies Human TIMP-1 ELISpot Development Kit from R&D Systems

Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMT...(catastrophic impact on our troops. ...)